Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MXAU | ISIN: GB00B1YPC344 | Ticker-Symbol: 1ZJ
Frankfurt
24.01.25
08:18 Uhr
6,650 Euro
+0,050
+0,76 %
Branche
Freizeitprodukte
Aktienmarkt
Sonstige
1-Jahres-Chart
FULLER SMITH & TURNER PLC Chart 1 Jahr
5-Tage-Chart
FULLER SMITH & TURNER PLC 5-Tage-Chart
RealtimeGeldBriefZeit
6,6007,05018:41
Dow Jones News
273 Leser
Artikel bewerten:
(1)

Fuller, Smith & Turner PLC: Holding(s) in Company

Finanznachrichten News

DJ Fuller, Smith & Turner PLC: Holding(s) in Company

Fuller, Smith & Turner PLC (FSTA) 
Fuller, Smith & Turner PLC: Holding(s) in Company 
22-Jan-2025 / 17:30 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
TR-1: Standard form for notification of major holdings 
1. Issuer Details 
ISIN 
GB00B1YPC344 
Issuer Name 
FULLER SMITH & TURNER PLC 
UK or Non-UK Issuer 
UK 
2. Reason for Notification 
An acquisition or disposal of voting rights 
3. Details of person subject to the notification obligation 
Name 
BlackRock, Inc. 
City of registered office (if applicable) 
Wilmington 
Country of registered office (if applicable) 
USA 
4. Details of the shareholder 
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above 
 
City of registered office (if applicable) 
 
Country of registered office (if applicable) 
 
5. Date on which the threshold was crossed or reached 
21-Jan-2025 
6. Date on which Issuer notified 
22-Jan-2025 
7. Total positions of person(s) subject to the notification obligation 
                % of voting rights   % of voting rights through   Total of both Total number of 
.                attached to shares   financial instruments (total of in % (8.A +  voting rights held 
                (total of 8.A)     8.B 1 + 8.B 2)         8.B)     in issuer 
Resulting situation on the date 
on which threshold was crossed Below 5%        Below 5%            Below 5%   Below 5% 
or reached 
Position of previous      9.920000        0.050000            9.970000 
notification (if applicable) 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN Number of direct voting Number of indirect voting % of direct voting  % of indirect voting 
code(if possible)     rights (DTR5.1)     rights (DTR5.2.1)     rights (DTR5.1)   rights (DTR5.2.1) 
GB00B1YPC344                   Below 5%                    Below 5% 
Sub Total 8.A       Below 5%                     Below 5% 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial  Expiration Exercise/     Number of voting rights that may be acquired if the    % of voting 
instrument     date    conversion period instrument is exercised/converted             rights 
Securities Lending                Below 5%                         Below 5% 
Sub Total 8.B1                  Below 5%                         Below 5% 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial    Expiration  Exercise/conversion  Physical or cash    Number of voting  % of voting 
instrument       date     period         settlement       rights       rights 
 
Sub Total 8.B2 

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate   Name of     % of voting rights if it  % of voting rights through financial Total of both if it 
controlling  controlled   equals or is higher than  instruments if it equals or is higher equals or is higher than 
person    undertaking   the notifiable threshold  than the notifiable threshold     the notifiable threshold 
BlackRock,  BlackRock 
Inc. (Chain  Finance, Inc. 
1) 
BlackRock,  BlackRock 
Inc. (Chain  Holdco 2, Inc. 
1) 
BlackRock,  BlackRock 
Inc. (Chain  Financial 
1)      Management, 
       Inc. 
BlackRock,  BlackRock 
Inc. (Chain  International 
1)      Holdings, Inc. 
BlackRock,  BR Jersey 
Inc. (Chain  International 
1)      Holdings L.P. 
BlackRock,  BlackRock 
Inc. (Chain  Holdco 3, LLC 
1) 
BlackRock,  BlackRock 
Inc. (Chain  Cayman 1 LP 
1) 
BlackRock,  BlackRock 
Inc. (Chain  Cayman West Bay 
1)      Finco Limited 
BlackRock,  BlackRock 
Inc. (Chain  Cayman West Bay 
1)      IV Limited 
BlackRock,  BlackRock Group 
Inc. (Chain  Limited 
1) 
BlackRock,  BlackRock 
Inc. (Chain  Finance Europe 
1)      Limited 
BlackRock,  BlackRock 
Inc. (Chain  Investment 
1)      Management (UK) 
       Limited 
BlackRock,  BlackRock 
Inc. (Chain  Finance, Inc. 
2) 
BlackRock,  BlackRock 
Inc. (Chain  Holdco 2, Inc. 
2) 
BlackRock,  BlackRock 
Inc. (Chain  Financial 
2)      Management, 
       Inc. 
BlackRock,  BlackRock 
Inc. (Chain  International 
2)      Holdings, Inc. 
BlackRock,  BR Jersey 
Inc. (Chain  International 
2)      Holdings L.P. 
BlackRock,  BlackRock 
Inc. (Chain  Holdco 3, LLC 
2) 
BlackRock,  BlackRock 
Inc. (Chain  Cayman 1 LP 
2) 
BlackRock,  BlackRock 
Inc. (Chain  Cayman West Bay 
2)      Finco Limited 
BlackRock,  BlackRock 
Inc. (Chain  Cayman West Bay 
2)      IV Limited 
BlackRock,  BlackRock Group 
Inc. (Chain  Limited 
2) 
BlackRock,  BlackRock 
Inc. (Chain  Finance Europe 
2)      Limited 
BlackRock,  BlackRock 
Inc. (Chain  Advisors (UK) 
2)      Limited 

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

BlackRock Regulatory Threshold Reporting Team Jana Blumenstein 020 7743 3650

12. Date of Completion

22nd January 2025

13. Place Of Completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00B1YPC344 
Category Code: HOL 
TIDM:      FSTA 
LEI Code:    213800C7ACOFMRCQQW76 
OAM Categories: 2.3. Major shareholding notifications 
Sequence No.:  372190 
EQS News ID:  2072943 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2072943&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

January 22, 2025 12:31 ET (17:31 GMT)

© 2025 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.